• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Abbott sales dip in Q3 due to COVID testing sales declines, infant formula manufacturing...

cafead

Administrator
Staff member
  • cafead   Oct 19, 2022 at 11:02: AM
via Abbott’s sales in Q3 totaled $10.4 billion, marking a decrease of 4.7%, though the company once again raised its full-year guidance.

The dip in the company’s sales were due in part to declines in COVID-19 testing-related sales and an abrupt infant formula production stoppage at one of its manufacturing plants earlier this year.

article source
 

<